Search

everythinglearnresearchcommunity

for

Search:↓

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Stem cells can be used to create long-lasting skin cells for treating pigment disorders.

Dual wavelength LED caps can safely increase hair density in androgenetic alopecia.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Squaric acid dibutylester promotes hair growth by activating immune cells, especially macrophages.

JAM-A helps hair regrowth in alopecia areata by protecting VCAN in skin cells.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The Hair660™ light therapy device effectively and safely improves hair density in people with androgenetic alopecia.

Danthron from Rhubarb causes melanoma cells to stop growing and die.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.